Taking into consideration increased levels of TNF-α in patients with RA and the obvious effect of TNF-α neutralization for the alleviation of arthritis, our finding of a low incidence of antibodies against TIMP-3 is unexpected. Here, TIMP3 is linked to arthritic joint disease.